Skip to content
MedsAcross

Brand family

Duetact

Glimepiride and Pioglitazone · Takeda Pharmaceuticals
United States
Presentations
2
Markets
1

Duetact is a brand of Glimepiride and Pioglitazone marketed by Takeda Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Glimepiride and Pioglitazone
Brand owner
Takeda Pharmaceuticals
Registered in
United States
Strengths and forms
2 mg/30 mg tablet, 4 mg/30 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Duetact 2 mg/30 mg tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Duetact 4 mg/30 mg tabletOralTakeda PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Duetact

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.